Vol 2, No 3 (June 2013): Translational Lung Cancer Research (Lung Cancer Issue-Guest Editors: Rafael Rosell, Niki Karachaliou)

Review Articles

Adaptive resistance to targeted therapies in cancer
Rafael Rosell, Niki Karachaliou, Daniela Morales-Espinosa, Carlota Costa, Miguel Angel Molina, Irene Sansano, Amaya Gasco, Santiago Viteri, Bartomeu Massuti, Jia Wei, María González Cao, Alejandro Martínez Bueno
Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)
Laura Bonanno
The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung
Niki Karachaliou, Rafael Rosell, Santiago Viteri
Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)
Jia Wei, Teresa Moran, Zhengyun Zou, Xiaoping Qian, Lifeng Wang, Carlos Camps, Wenjing Hu, Imane Chaib, Belén Sanchez, Lixia Xu, Niki Karachaliou, María Sanchez-Ronco, Baorui Liu, Rafael Rosell
State of the art of radiotherapy
Pilar Garrido, Mª Eugenia Olmedo
Management of elderly patients
Alain Vergnenegre, Romain Corre, Hervé Lena, Hervé Le Caer
Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?
Bartomeu Massuti, Jose Miguel Sanchez, Florentino Hernando-Trancho, Niki Karachaliou, Rafael Rosell
International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signature
Johannes R. Kratz, Michael J. Mann, David M. Jablons
Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients
Margarita Majem, Jordi Remon
Apoptotic agents
Dean A. Fennell
BRAF mutant non-small cell lung cancer and treatment with BRAF inhibitors
José Miguel Sánchez-Torres, Santiago Viteri, Miguel Angel Molina, Rafael Rosell
EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data
Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner